Document is current

Article History

Received: 27 December 2023

Accepted: 8 March 2024

First Online: 20 March 2024

Declarations

:

: The protocol adheres to the guidelines outlined by the Helsinki Declaration and Measures for Ethical Review of Biomedical Research Involving Humans has been approved by the Ethics Committee of Beijing Hospital, Capital Medical University (Ethical review No. 2023kky-064). The trial will be conducted under the supervision of the Department of Scientific Research Management of the Beijing Rehabilitation Hospital, Capital Medical University. All participants provided written informed consent before participation. This study was registered in the Chinese Clinical Trial Registry (ChiCTR2300071969).All participants must sign a written informed consent form. Participation is voluntary and patients can leave the study at any time. All of the data will be anonymized. We will establish multiple communication channels to maintain close contact with participants.

: Written informed consent was obtained from the patients for publication of this manuscript and any accompanying images. No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent forms are available from the corresponding author on request.

: The authors declare that they have no competing interests.